These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10554828)

  • 1. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.
    Astermark J; Petrini P; Tengborn L; Schulman S; Ljung R; Berntorp E
    Br J Haematol; 1999 Jun; 105(4):1109-13. PubMed ID: 10554828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
    Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
    Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.
    Fischer K; Van Der Bom JG; Prejs R; Mauser-Bunschoten EP; Roosendaal G; Grobbee DE; Van Den Berg HM
    Haemophilia; 2001 Nov; 7(6):544-50. PubMed ID: 11851751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
    Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.
    van den Berg HM; Fischer K; Mauser-Bunschoten EP; Beek FJ; Roosendaal G; van der Bom JG; Nieuwenhuis HK
    Br J Haematol; 2001 Mar; 112(3):561-5. PubMed ID: 11260054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres.
    Blanchette VS; McCready M; Achonu C; Abdolell M; Rivard G; Manco-Johnson MJ
    Haemophilia; 2003 May; 9 Suppl 1():19-26; discussion 26. PubMed ID: 12709033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands.
    van Dijk K; Fischer K; van der Bom JG; Scheibel E; Ingerslev J; van den Berg HM
    Br J Haematol; 2005 Jul; 130(1):107-12. PubMed ID: 15982352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.
    Pérez-Robles T; Romero-Garrido JA; Rodriguez-Merchan EC; Herrero-Ambrosio A
    Thromb Res; 2016 Jul; 143():22-7. PubMed ID: 27172834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.
    van den Berg HM; Fischer K; van der Bom JG; Roosendaal G; Mauser-Bunschoten EP
    Haemophilia; 2002 Mar; 8 Suppl 2():43-6. PubMed ID: 11966853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of joint damage in hemophilic children with early prophylaxis.
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-346. PubMed ID: 28246905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.
    Srivastava A; Rangarajan S; Kavakli K; Klamroth R; Kenet G; Khoo L; You CW; Xu W; Malan N; Frenzel L; Bagot CN; Stasyshyn O; Chang CY; Poloskey S; Qiu Z; Andersson S; Mei B; Pipe SW
    Lancet Haematol; 2023 May; 10(5):e322-e332. PubMed ID: 37003278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy.
    Van den Berg HM; Dunn A; Fischer K; Blanchette VS
    Haemophilia; 2006 Jul; 12 Suppl 3():159-68. PubMed ID: 16684012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iranian Low-dose Escalating Prophylaxis Regimen in Children with Severe Hemophilia A and B.
    Eshghi P; Sadeghi E; Tara SZ; Habibpanah B; Hantooshzadeh R
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):513-518. PubMed ID: 28049359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
    Marijke van den Berg H
    Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in hemophilia and the role of current and emerging prophylaxis.
    Acharya SS
    Am J Manag Care; 2016 Apr; 22(5 Suppl):s116-25. PubMed ID: 27266808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.